Navigation Links
Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in Children with Spinal Muscular Atrophy
Date:8/15/2014

, ISIS-SMNRx, and myotonic dystrophy type 1, ISIS-DMPKRx.

ABOUT ISIS PHARMACEUTICALS, INC.
Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 32 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, including neurological disorders, and cancer.  Isis' partner, Genzyme, is commercializing Isis' lead product, KYNAMRO®, in the United States and other countries for the treatment of patients with homozygous FH.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

ISIS PHARMACEUTICALS' FORWARD-LOOKING STATEMENT
This press release includes forward-looking statements regarding Isis' alliance with Biogen Idec, the discovery, development, activity, therapeutic and commercial potential and safety of ISIS-SMNRx and the discovery, development and therapeutic potential of an antisense drug for the treatment of spinal muscular atrophy.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis'
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Mallinckrodt Completes Acquisition Of Questcor Pharmaceuticals
2. Access Pharmaceuticals Awarded Japan Patent For MuGard And ProctiGard
3. CASI Pharmaceuticals Reports Second Quarter 2014 Financial Results
4. Immune Pharmaceuticals Announces Second Quarter 2014 Financial Results and Provides Update on Bertilimumab Commencement of Phase II Clinical Trials
5. Imprimis Pharmaceuticals Announces Second Quarter 2014 Financial Results and Provides Operational Update
6. Dipexium Pharmaceuticals Reports Second Quarter 2014 Financial and Operational Results
7. Valeant Pharmaceuticals Receives FTC Second Request Under Hart-Scott-Rodino
8. Rock Creek Pharmaceuticals Reports Second Quarter and Announces Clinical Update
9. AcelRx Pharmaceuticals Reports Second Quarter 2014 Financial Results
10. Inovio Pharmaceuticals Reports 2014 Second Quarter Financial Results
11. Absorption Pharmaceuticals CEO Jeff Abraham Discusses Promescent on KFI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015 Pulse ... issued a survey to Rosacea sufferers as part of their ... treatments Rosacea sufferers found effective for their Rosacea. The survey ... and comprised 47% men and 53% women. The ... survey participants did not consider or attempt to visit their ...
(Date:6/30/2015)... First Choice Wellness Care recently upgraded their ... is the only clinic in the greater ... The practice has recently expanded their services and added ... their focus in the procedure. They upgraded to the ... clearance, and superior service. "We,ve been providing ...
(Date:6/30/2015)... ALISO VIEJO, Calif. , June 30, 2015 ... from the PRISM II study showing that treatment ... statistically significant reduction in symptoms of pseudobulbar affect ... or stroke. PBA is a distressing condition characterized ... crying resulting from certain neurologic diseases or brain ...
Breaking Medicine Technology:84% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7
(Date:6/30/2015)... ... June 30, 2015 , ... ... it has more than doubled the size of its medical staff to further ... staff -- which includes physicians, nurse practitioners and physician assistants -- now totals ...
(Date:6/30/2015)... ... June 30, 2015 , ... From the moment a patient enters the office ... care that they receive and the luxury in which they are bathed. The ... proud to offer the same experience, just better! , Their office is a state-of ...
(Date:6/30/2015)... ... 30, 2015 , ... The U.S. Women's National Soccer Team will face the Costa Rica ... be on Sunday, August 16th at Heinz Field in Pittsburgh at 1:30 p.m. local time. ... Stadium in Chattanooga, TN. , The USA WNT previously played at Heinz Field in Pittsburgh ...
(Date:6/30/2015)... Buffalo, NY (PRWEB) , ... June 30, 2015 ... ... world’s newest oncology centers are partnering to improve access to cancer prevention, screening ... Lakeshore Cancer Center (LCC) have announced an affiliation that will see Roswell Park ...
(Date:6/30/2015)... ... ... After more than five years of research and development that includes ... specifically formulated for the unique skin of all people of color — is now ... time to help protect the skin of all people of color this July Fourth ...
Breaking Medicine News(10 mins):Health News:Lakeview Health, a Nationally Recognized Drug Rehabilitation Center in Florida, Doubles Size of Medical Staff 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 3Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 4Health News:USA vs. Costa Rica Tickets at Heinz Field in Pittsburgh and Finley Stadium in Chattanooga: Ticket Down Slashes Presale Ticket Prices for Costa Rica vs. USA WNT 2Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 2Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 4Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 5Health News:GlobalSun – The First Sunscreen Developed for All People of Color – Hits The Market 2
... linked to improved physical performance, ALEXANDRIA, Va., ... to "quick fixes" like caffeine and,performance-enhancing supplements, which ... their sex lives, they are losing sight of ... good night,s sleep., According to the 2008 ...
... that Declines in Ozone and Particle Pollution Have,Stalled, ... issued its annual report card on air pollution ... pollution: short-term particle,pollution, year-round particle pollution and ozone ... California, Pittsburgh, Pennsylvania, tops one of,the most polluted ...
... Inc. (NYSE: BKD ) announced today that it ... the market closes on Wednesday, May 7,2008. The Company ... on,Thursday, May 8, 2008 at 8:00 AM ET. The ... within the U.S.) or (706) 634-9069 (from,outside of the ...
... BALTIMORE, April 30 Retirement Living TV ... together to bring a compelling,dialogue on the ... Washington,Northern Virginia and Southern Delaware television markets ... Solutions. The nation,s leading,political and public leaders ...
... youngsters to play more outdoors , , WEDNESDAY, April 30 (HealthDay ... of trees have lower rates of asthma than children who ... , Researchers looked at asthma rates among children aged 4 ... age 15, in 42 service districts of New York City. ...
... Now the Only Treatment Approved to Both Reduce Exacerbations ... ... April 30 The,U.S. Food and Drug Administration today approved ... inhalation powder),for the reduction of exacerbations in patients with chronic ...
Cached Medicine News:Health News:Americans Get Physical After a Good Night in Bed 2Health News:Americans Get Physical After a Good Night in Bed 3Health News:Americans Get Physical After a Good Night in Bed 4Health News:American Lung Association Issues State of the Air Report: First City Outside California (Pittsburgh) Tops One of the Most-Polluted Lists 2Health News:American Lung Association Issues State of the Air Report: First City Outside California (Pittsburgh) Tops One of the Most-Polluted Lists 3Health News:American Lung Association Issues State of the Air Report: First City Outside California (Pittsburgh) Tops One of the Most-Polluted Lists 4Health News:Brookdale Announces First Quarter 2008 Release and Earnings Call 2Health News:Retirement Living TV Partners with Maryland Public Television to Address the Issue of Healthcare in America Through Its Series Healthcare '08: Search for Solutions 2Health News:Retirement Living TV Partners with Maryland Public Television to Address the Issue of Healthcare in America Through Its Series Healthcare '08: Search for Solutions 3Health News:Tree-Lined Streets Associated With Lower Childhood Asthma Rates 2Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 2Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 3Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 4
... Designed to inform decision making, ... patient data on demand. Clinicians ... to lab results, medication profiles, ... profiles, and clinical notes such ...
... Thermo Labsystems was designed specifically to combine ... such as the new fast dial system ... help to define this as a new ... interchangeable handle plate offers a custom fit ...
Research Series 2100 Adjustable-volume Pipette, 0.1-2.5 l, single-channel with adjustable-volume setting...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Medicine Products: